Bioorthogonally surface-edited extracellular vesicles based on metabolic glycoengineering for CD44-mediated targeting of inflammatory diseases.
Lim GT, You DG, Han HS, Lee H, Shin S, Oh BH, Kumar EKP, Um W, Kim CH, Han S, Lee S, Lim S, Yoon HY, Kim K, Kwon IC, Jo DG, Cho YW, Park JH.
Lim GT, et al.
J Extracell Vesicles. 2021 Mar;10(5):e12077. doi: 10.1002/jev2.12077. Epub 2021 Mar 12.
J Extracell Vesicles. 2021.
PMID: 33738083
Free PMC article.